Earth Science Tech (ETST) AI Stock Analysis

• Market Cap: $35.69M
• Dividend Yield: N/A
• Average Volume (3M): 79.33K
• Price to Earnings (P/E): 16.0
• Beta (1Y): 1.15
• Revenue Growth: 408.98%
• EPS Growth: 650.00%
• Country: US
• Employees: 32
• Sector: Healthcare
• Sector Strength: 70
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): <0.01
• Shares Outstanding: 297,397,900
• 10 Day Avg. Volume: 41,375
• 30 Day Avg. Volume: 79,331
• PEG Ratio: 0.02
• Price to Book (P/B): N/A
• Price to Sales (P/S): 1.51
• Price to Cash Flow (P/CF): 18.50
• P/FCF Ratio: 212.70
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

Earth Science Tech exhibits a promising financial position with strong revenue growth and profitability, supported by efficient cash flow management. Technical analysis presents a neutral stance, while valuation metrics indicate fair pricing. The lack of earnings call and corporate events data does not detract from its overall positive outlook.

Earth Science Tech Business Overview & Revenue Model

Company Description

Earth Science Tech (ETST) is a biotechnology company focused on the development, manufacturing, and commercialization of hemp-derived cannabidiol (CBD) products. Operating in the health and wellness sector, ETST primarily specializes in producing high-quality, full-spectrum CBD oil, which is utilized in a variety of consumer products such as dietary supplements, nutraceuticals, and personal care items. The company aims to promote health and wellness through the therapeutic benefits of cannabinoids, leveraging scientific research and innovation.

How the Company Makes Money

Earth Science Tech makes money through the sale of its CBD-based products. The company's primary revenue streams include direct sales to consumers via online platforms and partnerships with retail distributors. ETST capitalizes on the growing demand for natural health solutions by offering a diverse range of CBD-infused products. Additionally, the company engages in licensing agreements and collaborations with research institutions to further develop its product offerings and enhance its market presence. These strategic partnerships and product innovations are key factors contributing to ETST's earnings.

Earth Science Tech Financial Statement Overview

Summary

Earth Science Tech shows strong financial health with significant revenue growth, high gross profit margins, and robust cash flow management. The company has a remarkably high return on equity and minimal leverage, indicating low financial risk and strong potential for sustainable growth.

Income Statement

The company demonstrated significant revenue growth from 2023 to 2024, with TTM revenue reaching $30.45 million, a substantial increase from previous years. Gross profit margin stands strong at 60.7% for TTM, indicating effective cost management. Net profit margin is at 7.6%, showing profitability. EBIT and EBITDA margins are healthy at 21.2% and 22.6% respectively, reflecting strong operational efficiency. The positive trajectory in revenue and profitability highlights the company's growth potential.

Balance Sheet

The balance sheet shows a stable equity position with stockholders' equity at $3.28 million in TTM. The debt-to-equity ratio is low at 0.02, indicating minimal leverage and financial risk. Return on equity (ROE) is 70.5%, showcasing strong returns on shareholders' investments. However, the equity ratio is moderate at 57.5%, suggesting a balanced approach between debt and equity financing.

Cash Flow

The company has demonstrated strong cash flow management with a significant increase in free cash flow to $2.14 million in TTM. Operating cash flow to net income ratio is 0.98, showing efficient conversion of earnings to cash. The free cash flow to net income ratio is 0.93, indicating robust cash generation relative to profits. The positive cash flow trends suggest a healthy liquidity position and potential for reinvestment.

Breakdown
TTM	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Income Statement		Total Revenue
30.46M	11.95M	48.54K	14.12K	140.90K	526.14K
	Gross Profit
18.48M	7.83M	22.06K	-8.52K	39.93K	218.47K
	EBIT
6.45M	892.35K	-950.54K	-214.26K	-433.14K	-823.79K
	EBITDA
6.88M	1.04M	-300.48K	-224.28K	-4.30M	-874.99K
	Net Income Common Stockholders
2.31M	812.14K	144.58K	6.66M	-4.47M	-1.54M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
11.65K	697.72K	35.76K	26.94K	16.16K	30.72K
	Total Assets
13.15K	3.88M	2.69M	76.94K	64.56K	154.55K
	Total Debt
0.00	246.59K	974.11K	682.45K	650.44K	498.67K
	Net Debt
-11.65K	-451.13K	938.35K	655.50K	634.28K	467.95K
	Total Liabilities
49.99K	1.63M	1.61M	1.88M	5.09M	980.05K
	Stockholders Equity
-36.84K	2.25M	1.08M	-1.81M	-5.03M	-825.50K
Cash Flow		Free Cash Flow
2.14M	1.18M	-1.01M	-166.39K	-196.69K	-518.62K
	Operating Cash Flow
2.28M	1.21M	-1.01M	-168.11K	-196.69K	-518.62K
	Investing Cash Flow
-1.74M	-26.52K	0.00	1.71K	0.00	0.00
	Financing Cash Flow
-907.59K	-517.88K	1.02M	173.18K	182.12K	421.82K

Earth Science Tech Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.12
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ETST, the sentiment is Negative. The current price of 0.12 is below the 20-day moving average (MA) of 0.12, below the 50-day MA of 0.15, and below the 200-day MA of 0.16, indicating a bearish trend. The MACD of -0.01 indicates Negative momentum. The RSI at 41.05 is Neutral, neither overbought nor oversold. The STOCH value of 16.50 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ETST.

Earth Science Tech Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ETST	68 Neutral	$35.69M	16.00	85.03%	―	408.98%	650.00%
CRON	68 Neutral	$887.47M	16.37	3.80%	―	35.87%	―
Sector *	48 Neutral	$6.25B	1.14	-46.26%	2.69%	19.24%	1.75%
ACB	47 Neutral	$313.39M	25.51	4.78%	―	16.39%	-98.10%
CVSI	37 Underperform	$5.85M	―	-101.92%	―	-1.87%	-165.87%
CARA	29 Underperform	$22.25M	―	-270.01%	―	-65.96%	40.80%